Circulating Dickkof-1 as a potential biomarker associated with the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease
Chin Med J (Engl)
.
2021 Jan 11;134(9):1119-1121.
doi: 10.1097/CM9.0000000000001267.
Authors
Jing Xue
1
,
Yu-Jiao Wang
2
,
He-Chun Xia
3
,
Xue-Yun Liang
1
,
Jie-Da Cui
2
,
Min Yu
4
,
Xiao-Ming Liu
5
,
Shu-Hong Chi
6
,
Juan Chen
2
Affiliations
1
Institute of Human Stem Cell Research, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
2
Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
3
Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
4
Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
5
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, China.
6
Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
PMID:
33942802
PMCID:
PMC8116028
DOI:
10.1097/CM9.0000000000001267
No abstract available
MeSH terms
Arthritis, Rheumatoid* / complications
Biomarkers
Humans
Lung Diseases, Interstitial* / diagnosis
Lung Diseases, Interstitial* / etiology
Prognosis
Substances
Biomarkers